PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.24%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-23.67%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
31.24%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
37.04%
Margin expansion exceeding 1.5x VET's 0.28%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
710.60%
Other expenses growth above 1.5x VET's 60.13%. Michael Burry would check for concerning trends.
345.38%
Operating expenses growth less than half of VET's 3189.21%. David Dodd would verify sustainability.
29.07%
Total costs growth less than half of VET's 108.16%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
94.22%
D&A growth while VET reduces D&A. John Neff would investigate differences.
-21.56%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
51.60%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
-45.79%
Both companies show declining income. Martin Whitman would check industry conditions.
-43.39%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-961.59%
Other expenses reduction while VET shows 74.13% growth. Joel Greenblatt would examine advantage.
-110.35%
Both companies show declining income. Martin Whitman would check industry conditions.
-110.81%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-111.75%
Both companies reducing tax expense. Martin Whitman would check patterns.
-101.74%
Net income decline while VET shows 72.34% growth. Joel Greenblatt would examine position.
-101.82%
Net margin decline while VET shows 128.41% growth. Joel Greenblatt would examine position.
-101.90%
EPS decline while VET shows 86.96% growth. Joel Greenblatt would examine position.
-101.81%
Diluted EPS decline while VET shows 95.24% growth. Joel Greenblatt would examine position.
-7.67%
Share count reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.
-5.89%
Diluted share reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.